COVID-19: Now and Beyond

Posted by Ed Schoonveld on Tue, Mar 17, 2020

How does the COVID-19 pandemic impact the pharmaceutical industry and the drug pricing debate? In the short term, it may have caused a temporary break in the drug pricing media deluge, but it likely will create questions about new vaccine’s affordability and its ability to reach a broad patient population. As the disease’s spread continues to dominate the world stage, many pharmaceutical companies and university laboratories are working hard to identify treatment and vaccination options for COVID-19.


>
Read More